https://www.selleckchem.com/pr....oducts/remodelin.htm
As the incidence and prevalence of Crohn's disease continues to change worldwide, rates within North America have been increasing. The objective of this study was to evaluate whether patients who have Crohn's disease undergoing primary total hip arthroplasties have worse outcomes compared with matched cohorts. Specifically, we evaluated 1) medical complications, 2) in-hospital lengths of stay (LOS), and 3) costs of care. Two cohorts of patients who underwent primary total hip arthroplasties from January 1, 2005 to March 31, 2014 were